KRAS and neoplasm: Conditional oncogenic Kras mouse models developing endogenous PDAC recapitulate the complex tumor composition, aggressive tumor behavior and desmoplastic reaction and have consequently been used in various preclinical therapy trial settings including MR imaging guided trials also from our group21–23.